MedTrace Logo

New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors

NCT03895099 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-11-07

No results posted yet for this study

Summary

Oocyte donation is a cumbersome and demanding procedure, involving an injectable hormonal treatment for an average duration of 12 days, according to the protocols, 1 to several daily injections. The objective of this study is to show that treatments can be simplified without reducing the number of oocytes that have been punctured, by blocking the luteinizing hormone (LH) surge by using oral progesterone and by limiting the number of injections of gonadotropins using corifollitropin alpha, regardless of the start date of the pacing protocol during a natural cycle.

Conditions

Interventions

DRUG

Desogestrel early follicular phase

Start of ovarian stimulation in early follicular phase

DRUG

Desogestrel medium follicular phase

Start of ovarian stimulation in medium follicular phase

DRUG

Desogestrel ovulatory phase

Start of ovarian stimulation in ate follicular phase

DRUG

Desogestrel late follicular phase

Start of ovarian stimulation in ovulatory Phase

DRUG

Desogestrel luteal phase

Start of ovarian stimulation in luteal phase

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-04
Primary Completion
2023-10-30
Completion
2023-10-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03895099 on ClinicalTrials.gov